Characteristics of African American women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment Clinic

Gynecologic Oncology
David A BarringtonCharles A Leath

Abstract

Describe patient characteristics in African American (AA) women seen for gynecologic cancer related genetic counseling at a large southeastern comprehensive cancer center. We reviewed an IRB approved, prospective observational cohort of patients from a Gynecologic Cancer Risk Assessment Clinic. Data evaluated included personal cancer history, family history, frequency of genetic testing, frequency/type of genetic mutations, and frequency of surgical intervention. Standard statistical statistics were utilized. 1227 patients were evaluated from 2003 to 2015, of which 95 (7.7%) were AA. Sixteen patients had a personal history of ovarian cancer. 21 women (22%) underwent genetic counseling only; subsequent genetic testing was not recommended based on absence of risk factors. Of the seventy-four AA patients in whom genetic testing was recommended, sixty-six (69.5%) completed testing. Of women tested, 37 (56%) had abnormal results. Eight and 14 patients had pathogenic variants in BRCA1 and BRCA2, respectively. Two were found to have pathogenic PALB2 variants; one had a pathogenic ATM variant and one constitutional MLH1 epimutation case was identified. Eleven had BRCA variants of uncertain significance. Of the patients with abnormal te...Continue Reading

References

Apr 14, 2005·JAMA : the Journal of the American Medical Association·Katrina ArmstrongMary Putt
Jul 9, 2009·Journal of the National Cancer Institute·Kathy S AlbainDawn L Hershman
Oct 19, 2011·Proceedings of the National Academy of Sciences of the United States of America·Tom WalshElizabeth M Swisher
Oct 13, 2012·Genetic Testing and Molecular Biomarkers·Hayley S ThompsonHeiddis B Valdimarsdottir
Dec 26, 2012·Gynecologic Oncology·Ganna ChornokurCatherine M Phelan
Sep 10, 2013·Journal of Community Genetics·Tuya PalSusan Vadaparampil
Jan 28, 2015·Gynecologic Oncology·Lindsey E MinionBradley J Monk
Jan 1, 2016·JAMA Oncology·Barbara M NorquistMichael J Birrer
Jan 6, 2017·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Sep 22, 2017·Journal of Ovarian Research·Sanjeev K SrivastavaAjay P Singh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Related Papers

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Omar Moreira BachaMarie Plante
Archives of Gynecology and Obstetrics
Kerstin RhiemRita K Schmutzler
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Noah D KauffTimothy R Rebbeck
© 2022 Meta ULC. All rights reserved